From the Cancer Research United Kingdom (CRC) Institute for Cancer Studies, University of Birmingham; the Department of Histocompatibility & Immunogenetics, National Blood Service; the Department of Haematology, University Hospital Birmingham National Health Service (NHS) Trust; the Department of Haematology, Birmingham Heartlands & Solihull NHS Trust; and the Department of Haematology, Birmingham Children's Hospital NHS Trust, Birmingham, United Kingdom.
Killer immunoglobulin–like receptors (KIRs) regulate cell activity of natural killer (NK) cells and some T cells. The predominant ligand for inhibitory KIRs is HLA-C, which subdivides into 2 groups based on the specificity of inhibitory KIRs. The ligands for activatory KIRs are unknown. Following hematopoietic stem cell transplantation (HSCT), recipient tissues may not express a ligand for KIRs present within the graft, and the combination of donor KIR and recipient HLA-C types could influence outcome. HLA and KIR genotypes were determined in 220 donor-recipient pairs from HLA-matched sibling HSCTs performed for myeloid (n = 112) and lymphoid (n = 108) diseases. In HSCTs performed for myeloid disease, overall survival was worse in patients homozygous for group 2 HLA-C (C2) than in patients who carried a group 1 HLA-C (C1) allele (P < .005). Moreover, this effect is seen only when the donor additionally carries the activating KIR gene KIR2DS2 (P = .045). No effect was seen in patients with lymphoid disease. Thus, in HLA-matched sibling HSCT for myeloid leukemia, patients homozygous for C2 alleles receiving a graft from a donor carrying the KIR gene KIR2DS2 have a significantly reduced chance of survival.
Impact of blood coagulation and fibrinolytic system changes on early and mid term clinical outcome in patients undergoing stent endografting surgery
Impact of antioxidative treatment on nuclear factor kappa-B regulation during myocardial ischemia–reperfusion
Impact of coronary artery bypass grafting on survival after aortic valve replacement
Endovascular balloon versus transthoracic aortic clamping for minimally invasive mitral valve surgery: impact on cerebral microemboli
Impact of clopidogrel on postoperative blood loss after non-elective coronary bypass surgery
Impact of Renal Dysfunction on Outcomes of Coronary Artery Bypass Surgery
Impact of Prosthesis-Patient Mismatch on Long-Term Survival in Patients With Small St Jude Medical Mechanical Prostheses in the Aortic Position
Impact of Human Immunodeficiency Virus Infection on Cardiovascular Disease in Africa
Impact of Body Mass and Body Composition on Circulating Levels of Natriuretic Peptides
Impact of Prosthesis–Patient Size on Functional Recovery After Aortic Valve Replacement